Serveur d'exploration Tocilizumab - Curation (Accueil)

Index « AffRegInc.i » - entrée « Tokyo »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tokushukai Medical Corperation < Tokyo < Tokyo Medical and Dental University (TMDU)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]
Ident.Authors (with country if any)Title
000965 (2019) Masaru Kato [Japon] ; Yuko Kaneko [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Isao Yokota [Japon] ; Tatsuya Atsumi [Japon] ; Tsutomu Takeuchi [Japon]Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
000B11 (2019) Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon] ; Reiji Yamakawa [Japon]Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study.
000E37 (2019) Yoshiki Nagai [Japon] ; Naoto Yokogawa [Japon] ; Kota Shimada [Japon] ; Shoji Sugii [Japon]Comparison of the clinical characteristics and severity of community-acquired pneumonia between patients with rheumatoid arthritis treated with tocilizumab and those treated with TNF inhibitor.
000F93 (2019) Yoshihito Shima [Japon] ; Yasushi Kawaguchi [Japon] ; Masataka Kuwana [Japon]Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy.
001119 (2018) Hitoshi Imamura [Japon] ; Shigeki Momohara [Japon] ; Koichiro Yano [Japon] ; Yu Sakuma [Japon] ; Masanori Nakayama [Japon] ; Haruki Tobimatsu [Japon] ; Katsunori Ikari [Japon]Tocilizumab treatment in patients with rheumatoid arthritis is associated with reduced fibrinogen levels and increased blood loss after total knee arthroplasty.
001213 (2018) Tatsuya Atsumi [Japon] ; Keishi Fujio [Japon] ; Kunihiro Yamaoka [Japon] ; Minako Tomobe [Japon] ; Kazuyuki Kuroyanagi [Japon] ; Hideto Kameda [Japon]Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting.
001231 (2018) Yoko Shimizu [Japon] ; Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Kumi Shidara [Japon] ; Naoki Sugimoto [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon]Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.
001247 (2018) Tatsuya Atsumi [Japon] ; Yoshiaki Ando [Japon] ; Shinichi Matsuda [Japon] ; Shiho Tomizawa [Japon] ; Riwa Tanaka [Japon] ; Nobuhiro Takagi [Japon] ; Ayako Nakasone [Japon]Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database.
001345 (2018) I. Yokoe [Japon] ; H. Kobayashi [Japon] ; Y. Kobayashi [Japon] ; J T Giles [États-Unis] ; K. Yoneyama [Japon] ; N. Kitamura [Japon] ; M. Takei [Japon]Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.
001511 (2018) Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon]A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period.
001726 (2017) Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Rei Yamaguchi [Japon] ; Yoko Shimizu [Japon] ; Akiko Kobayashi [Japon] ; Naoki Sugimoto [Japon] ; Daisuke Hoshi [Japon] ; Kumi Shidara [Japon] ; Eri Sato [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon]Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.
001756 (2017) Yumi Tsuchida [Japon] ; Shuji Sumitomo [Japon] ; Hirofumi Shoda [Japon] ; Kanae Kubo [Japon] ; Keishi Fujio [Japon] ; Kazuhiko Yamamoto [Japon]Macrophage activation syndrome associated with tocilizumab treatment in adult-onset Still's disease.
001833 (2017) Naoki Ishiguro [Japon] ; Tatsuya Atsumi [Japon] ; Masayoshi Harigai [Japon] ; Tsuneyo Mimori [Japon] ; Norihiro Nishimoto [Japon] ; Takayuki Sumida [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Ayako Nakasone [Japon] ; Nobuhiro Takagi ; Hisashi Yamanaka [Japon]Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
001866 (2017) Xiaoping Zhang [États-Unis] ; Ya-Chi Chen [États-Unis] ; Kimio Terao [Japon]Clinical pharmacology of tocilizumab for the treatment of polyarticular-course juvenile idiopathic arthritis.
001929 (2017) Takeo Isozaki ; Shinichiro Nishimi ; Airi Nishimi ; Mayu Saito ; Yusuke Miwa ; Yoichi Toyoshima [Japon] ; Katsunori Inagaki [Japon] ; Tsuyoshi KasamaA disintegrin and metalloproteinase (ADAM)-10 as a predictive factor for tocilizumab effectiveness in rheumatoid arthritis.
001A01 (2016) Kayoko Kaneko [Japon] ; Maki Sugitani [Japon] ; Mikako Goto [Japon] ; Atsuko Murashima [Japon]Tocilizumab and pregnancy: Four cases of pregnancy in young women with rheumatoid arthritis refractory to anti-TNF biologics with exposure to tocilizumab.
001A28 (2016) Satoshi Hamanoue [Japon] ; Tatsuya Suwabe [Japon] ; Junichi Hoshino [Japon] ; Keiichi Sumida [Japon] ; Koki Mise [Japon] ; Noriko Hayami [Japon] ; Naoki Sawa [Japon] ; Kenmei Takaichi [Japon] ; Takeshi Fujii [Japon] ; Kenichi Ohashi [Japon] ; Masahide Yazaki [Japon] ; Shuichi Ikeda [Japon] ; Yoshifumi Ubara [Japon]Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
001A32 (2016) Ei Bannai [Japon] ; Hiroyuki Yamashita [Japon] ; Shunta Kaneko [Japon] ; Yo Ueda [Japon] ; Takashi Ozaki [Japon] ; Haruka Tsuchiya [Japon] ; Yuko Takahashi [Japon] ; Hiroshi Kaneko [Japon] ; Toshikazu Kano [Japon] ; Akio Mimori [Japon]Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
001A58 (2016) Masayoshi Harigai ; Toshihiro Nanki ; Ryuji Koike ; Michi Tanaka ; Kaori Watanabe-Imai ; Yukiko Komano ; Ryoko Sakai ; Hayato Yamazaki ; Takao Koike [Japon] ; Nobuyuki Miyasaka [Japon]Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
001A86 (2016) Ken Nakajima [Japon] ; Omi Watanabe [Japon] ; Mayumi Mochizuki [Japon] ; Ayako Nakasone [Japon] ; Nobuhiko Ishizuka [Japon] ; Atsuko Murashima [Japon]Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan.
001B11 (2016) Toshihiko Komai [Japon] ; Hirofumi Shoda [Japon] ; Kenichi Yamaguchi [Japon] ; Keiichi Sakurai [Japon] ; Mihoko Shibuya [Japon] ; Kanae Kubo [Japon] ; Toshiyuki Takahashi [Japon] ; Keishi Fujio [Japon] ; Kazuhiko Yamamoto [Japon]Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i -k "Tokyo " 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i  \
                -Sk "Tokyo " \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Tokyo 
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021